Long‐Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52‐Week, Multicenter, Single‐Arm Trial. - Guo, Xiaohui; Wang, Kailiang; Zhang, Tingting; Ma, Jianhua; Li, Yukun; Jiang, Chengxia; Liu, Jie; Zhang, Yawei; Bian, Fang; Zhang, Fang; Liu, Weijuan; Wu, Xiaohong; et al. (Journal of Diabetes Research, 2026)